SILDOSAF 4 CAPSULE

Product Description

SILDOSAF 4 CAPSULE contains Silodosin 4 mg, a potent and selective alpha-1 adrenergic receptor antagonist designed for the effective management of Benign Prostatic Hyperplasia (BPH). This capsule formulation helps relieve urinary symptoms by relaxing muscles in the prostate and bladder neck, ensuring smooth urine flow and enhanced patient comfort.

Trusted by healthcare professionals, SILDOSAF 4 CAPSULE is ideal for medical distributors, retailers, and bulk pharmaceutical buyers looking to offer a reliable solution for BPH treatment. Manufactured with stringent quality controls, this product guarantees consistent potency, safety, and therapeutic effectiveness.

Key Benefits:

• Contains Silodosin 4 mg, clinically proven to improve urinary flow in BPH patients

• Selective alpha-1 blocker reducing side effects compared to non-selective agents

• Enhances patient compliance with easy-to-administer capsule form

• Manufactured under GMP-certified facilities ensuring high-quality standards

Usage:

• Recommended for the treatment of lower urinary tract symptoms (LUTS) associated with BPH

• Helps reduce urinary hesitancy, frequency, and urgency

• Suitable for long-term management under medical supervision

Why Choose SILDOSAF 4 CAPSULE?

• Reliable formulation with high bioavailability and targeted action

• Competitive pricing and available for bulk purchase

• Excellent margin opportunities for pharma wholesalers and retailers